4.5 Article

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer

Journal

HUMAN MOLECULAR GENETICS
Volume 22, Issue 4, Pages 825-831

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/dds489

Keywords

-

Funding

  1. MRC
  2. Cancer Research UK
  3. Bayer
  4. Cancer Research UK [C1298/A8362, C490/A10124]
  5. Bobby Moore Fund
  6. Leukaemia Lymphoma Research
  7. NHS
  8. Intramural Research Program of the National Cancer Institute, NIH
  9. Cancer Research UK [6858] Funding Source: researchfish
  10. Medical Research Council [MC_UU_12023/4, MC_U122861326] Funding Source: researchfish
  11. MRC [MC_UU_12023/4, MC_U122861326] Funding Source: UKRI

Ask authors/readers for more resources

Genome-wide association studies (GWASs) of renal cell cancer (RCC) have identified four susceptibility loci thus far. To identify an additional RCC common susceptibility locus, we conducted a GWAS and performed a meta-analysis with published GWASs (totalling 2215 cases and 8566 controls of European background) and followed up the most significant association signals [nine single nucleotide polymorphisms (SNPs) in eight genomic regions] in 3739 cases and 8786 controls. A combined analysis identified a novel susceptibility locus mapping to 2q22.3 marked by rs12105918 (P 1.80 10(8); odds ratio 1.29, 95 CI: 1.181.41). The signal localizes to intron 2 of the ZEB2 gene (zinc finger E box-binding homeobox 2). Our findings suggest that genetic variation in ZEB2 influences the risk of RCC. This finding provides further insights into the genetic and biological basis of inherited genetic susceptibility to RCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available